Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ponzoni

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Neurology|May 10, 2006
MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomasA J M Ferreri, S Dell'Oro, M Foppoli, et al.
Leukemia|December 16, 2006
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patientsS A Pileri, S Ascani, M C Cox, et al.
Neurology|May 30, 2002
A multicenter study of treatment of primary CNS lymphomaA J M Ferreri, M Reni, F Pasini, et al.
British Journal of Haematology|June 9, 2007
Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomasM Ponzoni, F Berger, C Chassagne-Clement, et al.
Leukemia|June 8, 2007
Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)C Tarella, M Zanni, M Di Nicola, et al.
Leukemia|June 18, 2014
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromesM G Della Porta, E Travaglino, E Boveri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Anthracycline-based chemotherapy as primary treatment for intravascular lymphomaA J M Ferreri, E Campo, A Ambrosetti, et al.
Leukemia|January 7, 2012
Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implicationsV Bikos, N Darzentas, A Hadzidimitriou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2011
Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletionM Mian, M Scandurra, E Chigrinova, et al.
Leukemia|July 27, 2017
Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapyZ Yao, L Deng, Z Y Xu-Monette, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Neurology|May 10, 2006
MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomasA J M Ferreri, S Dell'Oro, M Foppoli, et al.
Leukemia|December 16, 2006
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patientsS A Pileri, S Ascani, M C Cox, et al.
Neurology|May 30, 2002
A multicenter study of treatment of primary CNS lymphomaA J M Ferreri, M Reni, F Pasini, et al.
British Journal of Haematology|June 9, 2007
Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomasM Ponzoni, F Berger, C Chassagne-Clement, et al.
Leukemia|June 8, 2007
Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)C Tarella, M Zanni, M Di Nicola, et al.
Leukemia|June 18, 2014
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromesM G Della Porta, E Travaglino, E Boveri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Anthracycline-based chemotherapy as primary treatment for intravascular lymphomaA J M Ferreri, E Campo, A Ambrosetti, et al.
Leukemia|January 7, 2012
Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implicationsV Bikos, N Darzentas, A Hadzidimitriou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2011
Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletionM Mian, M Scandurra, E Chigrinova, et al.
Leukemia|July 27, 2017
Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapyZ Yao, L Deng, Z Y Xu-Monette, et al.
Pageof 12